Securing retatrutide can be a challenge for many. Currently, the drug is restricted and necessitates a prescription from a medical provider. Receiving retatrutide typically involves participating in a investigative program, though anticipated expanded distribution through traditional pharmaceutical channels is under review – though a timeframe fo